NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Unichem Laboratories Limited (NSE: UNICHEMLAB)

 
UNICHEMLAB Technical Analysis
3
As on 31st Mar 2023 UNICHEMLAB SHARE Price closed @ 289.70 and we RECOMMEND Sell for LONG-TERM with Stoploss of 313.76 & Sell for SHORT-TERM with Stoploss of 302.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

UNICHEMLABSHARE Price

Open 288.50 Change Price %
High 297.45 1 Day 2.65 0.92
Low 287.40 1 Week 6.65 2.35
Close 289.70 1 Month -9.25 -3.09
Volume 79555 1 Year 29.80 11.47
52 Week High 365.20 | 52 Week Low 198.75
 
NSE INDIA Most Active Stocks
BCG 14.60 9.77%
IDEA 5.80 -1.69%
YESBANK 15.05 0.67%
BEL 97.55 6.55%
SOUTHBANK 14.65 1.74%
GTLINFRA 0.70 7.69%
SUZLON 7.90 -0.63%
ZOMATO 51.00 -0.49%
JPPOWER 5.55 -0.89%
VEDL 274.45 -2.59%
 
NSE INDIA Top Gainers Stocks
SOUTHWEST 111.70 19.98%
MITTAL 9.65 19.88%
TRU 53.20 19.82%
TRU 53.20 19.82%
TRU 53.20 19.82%
TRU 53.20 19.82%
TRU 53.20 19.82%
PRAKASHSTL 3.95 19.70%
SGL 15.35 19.46%
SGL 15.35 19.46%
 
NSE INDIA Top Losers Stocks
TARAPUR 2.80 -12.50%
BURNPUR 4.55 -9.00%
ANTGRAPHIC 0.55 -8.33%
TECHIN 6.60 -7.04%
LFIC 117.50 -6.60%
GINNIFILA 16.90 -5.85%
SWSOLAR 291.60 -5.55%
IMPAL 594.20 -5.40%
GPIL 348.90 -5.18%
SHREYAS 239.35 -5.10%
 
 
UNICHEMLAB
Daily Charts
UNICHEMLAB
Intraday Charts
Whats New @
Bazaartrend
UNICHEMLAB
Free Analysis
 
UNICHEMLAB Important Levels Intraday
RESISTANCE309.07
RESISTANCE302.86
RESISTANCE299.02
RESISTANCE295.18
SUPPORT284.22
SUPPORT280.38
SUPPORT276.54
SUPPORT270.33
 
UNICHEMLAB Target March 2023
4th UP Target518.15
3rd UP Target460.58
2nd UP Target425
1st UP Target389.42
1st DOWN Target287.88
2nd DOWN Target252.3
3rd DOWN Target216.72
4th DOWN Target159.15
 
UNICHEMLAB Weekly Target
4th UP Target341.25
3rd UP Target322.58
2nd UP Target311.05
1st UP Target299.51
1st DOWN Target266.59
2nd DOWN Target255.05
3rd DOWN Target243.52
4th DOWN Target224.85
 
UNICHEMLAB Target2023
4th UP Target833.87
3rd UP Target667.66
2nd UP Target564.92
1st UP Target462.18
1st DOWN Target169.02
2nd DOWN Target66.28
3rd DOWN Target-36.46
4th DOWN Target-202.67
 
 
UNICHEMLAB Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is Below 20 Over Sold
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 108.34
10 Day Avg Volume Traded -7.52 % Less then 10 Day Average Volume
 
UNICHEMLAB Other Details
Segment EQ
Market Capital 17080448000.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
UNICHEMLAB Address
UNICHEMLAB
 
UNICHEMLAB Latest News
 
Your Comments and Response on Unichem Laboratories Limited
 
UNICHEMLAB Business Profile
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients. The company was founded in 1944 and is headquartered in Mumbai, India. Address: Unichem Bhavan, Mumbai, India, 400102
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service